ClinicaliQ Trial Snapshot
- An Investigation Into Dielectric Testing for the Evaluation and Characterisation of Breast Tissue Using a Novel Time-Domain Bioimpedance Tool — Recruiting • Oncology • NCT07782814.
- What is being tested: A novel time-domain bioimpedance device that measures dielectric properties (capacitance) of breast tissue to differentiate between healthy and abnormal tissue based on their electrical characteristics.
- Patient eligibility overview: The study recruits women undergoing breast assessment or intervention, likely including those with suspicious lesions requiring diagnostic evaluation or biopsy to provide tissue comparison samples.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Capacitance measures a material's ability to store the movement of electrical energy in the electric field. Different of the human body are known to have different capacitance values. Research is looking into utilising capacitance differences, using a method called bioimpedance, to detect signatures of cancer. Breast cancer is the most common type of cancer in women globally, and the bioimpedance of healthy breast tissue is different to cancer tissue. Breast tissue is accessible by non-invasive means and has well-established clinical tools for cancer detection. However, results from studies vary and…
Eligibility Snapshot
- : * Attending a breast clinic appointment or other appointment at a participating site * Assigned female sex at time of birth * Aged 18 years or older at time of scan * Willing, able and mentally competent to read, understand, and provide informed consent in English * Patients who wish to enter the NACT sub-study, inclusion in NACT care is required.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.